Biohaven Ltd. Ratios | P/E, ROE & Valuation

On the Key Ratios page for Biohaven Ltd. (BHVN), the latest P/E of -3.4 frames valuation, while ROE -1328.94% and ROIC -181.44% indicates profitability and capital efficiency. Together with the current ratio of 4.73 and debt-to-equity 24.30, these signals help you judge whether valuation is supported by fundamentals across the historical rows.

Financial Performance Ratios

BHVN Historical Per Share Metrics

9 years
Metric (FY)TTM20242023202220212020201920182017
Revenue per Share$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Net Income per Share$-3.90$-9.28$-5.73$-12.75$-5.97$-3.31$-10.91$0.00$0.00
Operating Cash Flow per Share$-3.39$-6.38$-4.66$-6.65$-4.07$-2.12$-7.78$0.00$0.00
Free Cash Flow per Share$-3.40$-6.43$-4.70$-7.57$-4.10$-2.20$-7.83$0.00$0.00
Cash per Share$1.78$5.33$5.36$10.40$2.12$2.30$6.53$0.00$0.00
Book Value per Share$0.08$4.64$6.01$12.04$2.64$2.14$-0.15$0.00$0.00
Tangible Book Value per Share$-0.05$4.42$5.73$11.60$2.09$1.05$-0.15$0.00$0.00
Interest Debt per Share$1.97$0.40$0.43$0.75$0.09$0.10$-0.26$0.00$0.00
CAPEX per Share$0.00$0.04$0.04$0.92$0.03$0.08$0.05$0.00$0.00

BHVN Historical Valuation Ratios

9 years
Metric (FY)TTM20242023202220212020201920182017
Price to Earnings (P/E)-3.38-4.03-7.47-1.09-1.22-2.2-0.6700
Price to Book (P/B)193.388.057.121.157.5415.58-47.6800
Price to Sales (P/S)000000000
Enterprise Value to EBITDA-4.21-3.81-6.59-0.79-0.87-1.6-0.0800
EV to Sales000000000
EV to Operating Cash Flow-4.73-5.74-8.53-1.51-1.29-2.4-0.10.741.39
EV to Free Cash Flow-4.73-5.7-8.45-1.33-1.29-2.32-0.10.731.38
Enterprise Value$2.42B$3.35B$2.83B$449.73M$188.69M$182.61M$37.25M$-146.73M$-131.47M

BHVN Historical Profitability Ratios

9 years
Metric (FY)TTM20242023202220212020201920182017
Return on Equity (ROE)-1328.94%-199.89%-95.37%-105.85%-616.29%-707.16%7122.91%0.00%0.00%
Return on Invested Capital (ROIC)-181.44%-189.09%-93.58%-92.72%-219.07%-138.01%-172.43%0.00%0.00%
Return on Tangible Assets-167.22%-142.18%-82.72%-88.83%-174.85%-163.88%-153.60%0.00%0.00%
Earnings Yield-24.83%-24.84%-13.39%-91.83%-81.76%-45.38%-149.39%0.00%0.00%
Free Cash Flow Yield-21.67%-17.21%-10.99%-54.55%-56.13%-30.08%-107.31%0.00%0.00%
Dividend Yield0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

BHVN Historical Liquidity & Financial Strength

9 years
Metric (FY)TTM20242023202220212020201920182017
Current Ratio4.733.497.986.522.2634.9613.9414.49
Interest Coverage00000037.6900
Income Quality0.870.690.810.520.680.640.710.820.75
Debt to Equity24.30.090.070.060.090.2100.780
Debt to Assets80.12%5.95%6.02%5.08%2.28%3.23%0.00%40.52%0.00%
Net Debt to EBITDA-0.10.070.510.30.330.690.6600

BHVN Historical Efficiency Ratios

9 years
Metric (FY)TTM20242023202220212020201920182017
Receivables Turnover000000000
Payables Turnover0.1700000.03000
Inventory Turnover000000000
Days Sales Outstanding000000000
Days Payables Outstanding2141.22000013981.53000
Days of Inventory on Hand00000200562.43000

BHVN Historical Market Metrics

9 years
Metric (FY)TTM20242023202220212020201920182017
Enterprise Value to EBITDA-4.21-3.81-6.59-0.79-0.87-1.6-0.0800
Market Cap$2.36B$3.41B$3.05B$621.01M$261.51M$261.51M$353.98M$0.00$0.00
Enterprise Value$2.42B$3.35B$2.83B$449.73M$188.69M$182.61M$37.25M$-146.73M$-131.47M
Dividend Yield0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Payout Ratio0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions

How does Biohaven Ltd.’s P/E ratio compare with its history?

On this page, you can use the latest P/E (from the Key Ratios table) as your starting point and compare it to the company's multi-year P/E range in the historical rows. When the current P/E sits near its historical average, the multiple is close to that range. Look at trend direction in profitability and cash-flow rows, plus liquidity and leverage, rather than treating the P/E in isolation.

What is Biohaven Ltd. market cap?

Market cap is the market value of a company's equity and is commonly calculated as share price multiplied by shares outstanding. The latest market cap shown in the table is $2.36B. Pair market cap with valuation multiples (P/E, P/B, P/S) so you can evaluate whether size also corresponds with "quality" and profitability. For a wider view across stocks, you can also use the stock screener.

How does Biohaven Ltd.’s P/E compare with its industry?

There is no P/E Tickerplace rates as good. Compare the P/E on this page with Biohaven Ltd.'s own historical range (in the table) and with peers via the Screener and Compare tools. A higher or lower multiple versus peers is a calculated gap, not a recommendation.

How does Biohaven Ltd. compare to its competitors in key financial ratios?

The fastest way to compare Biohaven Ltd. with competitors is to use the built-in "Peers Comparison" section on this page and the Compare tool. Focus on a small set of ratios that work together: P/E for valuation, ROE/ROIC for profitability and capital efficiency, current ratio and interest coverage for liquidity and solvency, and debt-to-equity for leverage risk. When you see Biohaven Ltd. outperform peers on profitability while keeping valuation and leverage reasonable, it often signals stronger fundamentals.

What do Biohaven Ltd.'s liquidity and leverage ratios show?

Liquidity and leverage figures on this page are published ratios, not a verdict that Biohaven Ltd. is financially strong. Current ratio is about 4.73, which is above 1.0 and can indicate more comfortable short-term liquidity. Interest coverage is about 0.00, implying less buffer for servicing interest costs. Debt-to-equity is about 24.30, suggesting higher leverage than a low-debt profile. Pair them with ROE/ROIC and cash-flow rows in the table. Tickerplace does not rate the company as a good or poor investment.

What do Biohaven Ltd.'s financial ratios say about its future growth?

Ratios are a way to see what the business is likely to sustain. Look for upward trends in profitability metrics (ROE and ROIC), improving earnings/cash-flow backed measures, and stable or strengthening liquidity. If Biohaven Ltd. is sustaining strong returns (for example ROE at -1328.94% and ROIC at -181.44%) while debt levels and interest coverage remain manageable, growth expectations may be more credible. If valuation multiples expand while returns weaken, the market may be pricing optimistic growth ahead of results.